Ta‐Chun Yuan

831 citations
11 papers · 636 indexed · h-index 10
Topics
Prostate Cancer Treatment and Research (5 papers)Ubiquitin and proteasome pathways (3 papers)RNA modifications and cancer (2 papers)
Partner nations
United StatesTaiwanJapan

In The Last Decade

Ta‐Chun Yuan

11 papers receiving 624 citations

Peers

Ta‐Chun Yuan
Comparison fields: 5 of 70
  • Molecular Biology 378
  • Pulmonary and Respiratory Medicine 324
  • Oncology 141
  • Cancer Research 114
  • Genetics 67
Replace Robert Delsite with:
Robert Delsite United States
César Torres Brazil
Youyuan Xu United States
Shi Chang United States
Shi‐Ming Chang United States
Ulrike Seay Germany
Ulrich Hermanto United States
Laura R. Bohrer United States
Kevin McMahon Ireland
Allen Saliganan United States
Ta‐Chun Yuan relative to Robert Delsite United States Robert Delsite's profile →
Citations per field
00.5×1.6×
Robert Delsite · 1×
Citations per year

Countries citing papers authored by Ta‐Chun Yuan

Since Specialization
Citations

This map shows the geographic impact of Ta‐Chun Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ta‐Chun Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ta‐Chun Yuan more than expected).

Fields of papers citing papers by Ta‐Chun Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ta‐Chun Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ta‐Chun Yuan. The network helps show where Ta‐Chun Yuan may publish in the future.

Co-authorship network of co-authors of Ta‐Chun Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Ta‐Chun Yuan. A scholar is included among the top collaborators of Ta‐Chun Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ta‐Chun Yuan. Ta‐Chun Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 4
2 19
3 179
4 126
5 51
6 78
7 18
8 54
9 33
10 48
11 26

About Ta‐Chun Yuan

Ta‐Chun Yuan is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 11 papers that have together received 636 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Ubiquitin and proteasome pathways (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (324 citations), Cancer Research (114 citations) and Molecular Biology (378 citations). Ta‐Chun Yuan has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include Ming‐Fong Lin, Suresh Veeramani, Fen-Fen Lin, Tsukasa Igawa, Surinder K. Batra, Ming‐Shyue Lee, Stanislav Zelivianski, Dev Karan, Syed Shaheduzzaman and Dmitry Kondrikov. Their work appears in journals such as Oncogene, Cellular Signalling and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026